ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer

This study has been completed.
Study NCT00034151.   Last updated on November 6, 2008.   Information provided by OncoGenex Pharmaceuticals
Please refer to this study by its ClinicalTrials.gov identifier: NCT00034151


Sponsors and Collaborators
OncoGenex Pharmaceuticals


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers